Video

Positive visual outcomes reported one year following monocular implantation of small aperture IOL

Author(s):

David Hutton,Emily Kaiser Maharjan
Conferences|AAO

Mark H. Blecher, MD, dives into his AAO 2022 topic: "One-Year Visual Outcomes Following Monocular Implantation with a Small Aperture IOL."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
Related Content
Q&A: David S. Boyer, MD, on the suprachordial delivery of gene therapy
June 5th 2025

Q&A: David S. Boyer, MD, on the suprachordial delivery of gene therapy

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Opus Genetics releases topline results from LYNX-2 evaluating phentolamine ophthalmic solution 0.75%
June 2nd 2025

Opus Genetics releases topline results from LYNX-2 evaluating phentolamine ophthalmic solution 0.75%

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Q&A: Sharon Fekrat, MD, FACS, FASRS, on the value of scientific meetings and collaboration
May 31st 2025

Q&A: Sharon Fekrat, MD, FACS, FASRS, on the value of scientific meetings and collaboration

Q&A: Dilraj S. Grewal, MD, FASRS, on therapeutics for non-infectious uveitis
May 30th 2025

Q&A: Dilraj S. Grewal, MD, FASRS, on therapeutics for non-infectious uveitis

© 2025 MJH Life Sciences

All rights reserved.